Resources: Pillar 5: SGLT-2 inhibitors SGLT-2 inhibitors lower glucose by increasing urinary glucose excretion, reducing glucose toxicity, and often reducing insulin requirements, without directly increasing insulin
How do GLP-1 medications work: single, dual, and triple agonists
Finally, with the introduction of the first glucagon radioimmunoassay by Roger Unger and colleagues in 1959 [10], it became possible to measure plasma concentrations of glucagon allowing physiological studies of glucagon and its role in pathophysiological processes
Although no firm causality was demonstrated, and recent observational data are reassuring, it seems prudent to screen for depression and anxiety as common comorbidities in clinical practice [133, 143,144,145,146,147]
Metabolic regulation of macrophages during tissue repair: insights from skeletal muscle regeneration
Alopecia areata and autoimmune hair loss Autoimmune conditions cause the immune system to attack hair follicles